Skip to main content

Abstract

Autoimmune uveitis (AU) is an important cause of blindness and should be diagnosed as early as possible and efficiently treated in order to avoid it. It can be due to an isolated type of autoimmune reaction against the uveal components, or be related to or precede a known systemic autoimmune disease. A diagnosis of a systemic autoimmune disease should be investigated and the patient’s treatment should be tuned in accordance with the other organs involved. The autoimmune diseases where uveitis is most commonly seen are spondyloarthrophaties, inflammatory bowel disorders, juvenile idiopathic arthritis and Behçet’s disease.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 219.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 279.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 379.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bora NS, Sohn JH, Kang SG, et al. Type I collagen is the autoantigen in experimental anterior uveitis. J Immunol 2004; 172: 7086–94.

    CAS  PubMed  Google Scholar 

  2. Rivera-Cívico F, Jiménez-Alonso J, Martin-Armada M, et al. HLA-B27+ anterior uveitis with or without associated spondyloarthritis: Clinical and immunological features. Ann Rheum Dis 1999; 58: 721–2.

    Article  PubMed  Google Scholar 

  3. Grassi A, Corona F, Casellato A, Canelli V, Bardare M. Prevalence and outcome of juvenile idiopathic arthritis-associated uveitis and relation to articular disease. J Rheumatol 2007; 34(5): 1139–45.

    PubMed  Google Scholar 

  4. Sampaio-Barros PD, Conde RA, Bonfiglioli R, Bértolo MB, Samara AM. Characterization and outcome of uveitis in 350 patients with spondyloarthropathies. Rheumatol Int 2006; 26: 1143–6.

    Article  PubMed  Google Scholar 

  5. Banares A, Hernández-García C, Fernández-Gutiérrez B, Jover JA. Eye involvement in the spondyloarthropathies. Rheum Dis Clin North Am 1998; 24: 771–84.

    Article  CAS  PubMed  Google Scholar 

  6. Petty RE, Southwood TR, Manners P, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: Second revision, Edmonton, 2001. J Rheumatol 2004; 31(2): 390–2.

    PubMed  Google Scholar 

  7. Miller M. Juvenile Rheumatoid Arthritis. eMedicine Specialties >Pediatrics >Rheumatology. 2006.

    Google Scholar 

  8. Ravelli A, Martini A. Juvenile idiopathic arthritis. Lancet 2007; 369(9563): 767–78.

    Article  CAS  PubMed  Google Scholar 

  9. Edelsten C, Lee V, Bentley CR, Kanski JJ, Graham EM. An evaluation of baseline risk factors predicting severity in juvenile idiopathic arthritis associated uveitis and other chronic anterior uveitis in early childhood. Br J Ophthalmol 2002; 86: 51–56.

    Article  PubMed  Google Scholar 

  10. Cassidy J, Kivlin J, Lindsley C, Nocton J. Ophthalmologic examinations in children with juvenile rheumatoid arthritis. Pediatrics 2006; 117(5): 1843–5.

    Article  PubMed  Google Scholar 

  11. Foeldvari I, Wierk A. Methotrexate is an effective treatment for chronic uveitis associated with juvenile idiopathic arthritis. J Rheumatol 2005; 32(2): 362–5.

    CAS  PubMed  Google Scholar 

  12. Foeldvari I, Nielsen S, Kummerle-Deschner J, et al. Tumor necrosis factor-alpha blocker in treatment of juvenile idiopathic arthritis-associated uveitis refractory to second-line agents: Results of a multinational survey. J Rheumatol 2007; 34(5): 1146–50.

    CAS  PubMed  Google Scholar 

  13. International Study Group of Behçet's Disease. Criteria for diagnosis of Behçet's disease. Lancet 1990; 335: 1078–80.

    Google Scholar 

  14. Demiroglu H, Dundar S. Effects of age, sex, and initial presentation on the clinical course of Behçet's syndrome. South Med J 1997; 90: 567.

    Google Scholar 

  15. Takamoto M, Kaburaki T, Numaga J, et al. Long-term infliximab treatment for Behçet’s disease. Jap J Ophthalmol 2007; 51: 239–40.

    Article  Google Scholar 

  16. Moller DR. Etiology of sarcoidosis. Clin Chest Med 1997; 18: 695–706.

    Article  CAS  PubMed  Google Scholar 

  17. Power WJ, Neves RA, Rodriguez A, et al. The value of combined serum angiotensin-converting enzyme and gallium scan in diagnosing ocular sarcoidosis. Ophthalmology 1995; 102: 2007–11.

    CAS  PubMed  Google Scholar 

  18. Cano-Parra J, Díaz-LLopis M. New drugs in the treatment of noninfectious uveitis. Arch Soc Esp Oftalmol 2006; 81: 671–4.

    Article  CAS  PubMed  Google Scholar 

  19. Lim LL, Fraunfelder FW, Rosenbaum JR. Do tumor necrosis factor inhibitors cause uveitis? A registry-based study. Arthritis Rheum 2007; 56(10): 3248–52.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Humana Press, a part of Springer Science+Business Media, LLC

About this chapter

Cite this chapter

de Andrade, F.A., Foeldvari, I., Levy, R.A. (2008). Autoimmune Uveitis. In: Shoenfeld, Y., Cervera, R., Gershwin, M.E. (eds) Diagnostic Criteria in Autoimmune Diseases. Humana Press. https://doi.org/10.1007/978-1-60327-285-8_85

Download citation

Publish with us

Policies and ethics